Discovery of a Novel Ubenimex Derivative as a First-in-Class Dual CD13/Proteasome Inhibitor for the Treatment of Cancer.
Saved in:
| Title: | Discovery of a Novel Ubenimex Derivative as a First-in-Class Dual CD13/Proteasome Inhibitor for the Treatment of Cancer. |
|---|---|
| Authors: | Zhang, Jian1 (AUTHOR) zhangjian_3323@163.com, Sun, Simin2 (AUTHOR) lixiaoyang@ouc.edu.cn, Liu, Jinyu2 (AUTHOR), Zhang, Liang2 (AUTHOR), Guo, Di1 (AUTHOR), Zhang, Naixin3 (AUTHOR), Zhao, Jun4 (AUTHOR), Kong, Dexin3 (AUTHOR), Xu, Tongqiang4 (AUTHOR), Wang, Xuejian1 (AUTHOR), Xu, Wenfang4,5 (AUTHOR), Li, Xiaoyang2,4,5 (AUTHOR), Jiang, Yuqi2,4 (AUTHOR) jiangyuqi@ouc.edu.cn |
| Source: | Molecules. Sep2023, Vol. 28 Issue 17, p6343. 17p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14203049 |
|---|---|
| DOI: | 10.3390/molecules28176343 |
